Recombinant Human FSTL3 Protein

产品描述纤维蛋白原（Fibrinogen，Fg），即凝血因子I，分子量约340kDa，由α、β、γ三对不同多肽链组成，多肽链间以二硫键相连。α链分子量63.5kDa，β链分子量56kDa，γ链分子量47kDa，纤维蛋白原约含4%碳水化合物。纤维蛋白原参与凝血的原理：在凝血酶作用下，α链与β链分别释放出A肽与B肽，生成纤维蛋白单体。在此过程中，由于释放了酸性多肽，负电性降低，单体易于聚合成纤维蛋白多聚体，但此时单体之间借氢键与疏水键相连，尚可溶于稀酸和尿素溶液中。进一步在Ca2+与活化的ⅩⅢ因子作用下，单体之间以共价键相连，则变成稳定的不溶性纤维蛋白凝块，完成凝血过程。来源于不同物种（如来源于牛、猫、狗、豚鼠、人、绵羊、小鼠和大鼠等）的纤维蛋白原具有相似的结构和性质。因此，一般来源于一种哺乳动物的纤维蛋白原可与其他来源的凝血酶交叉反应，相反地来自一种哺乳动物蛋白的凝血酶液也可注入多种动物，发生凝血反应。IdeS 具有独特的底物选择性，可以作为工具酶应用于抗体类药物或抗体融合蛋白药物的结构表征分析。Recombinant Human FSTL3 Protein,His Tag

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 .The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Before binding to the ACE-2 receptor, structural analysis of the S1 trimer shows that only one of the three RBD domains is in the "up" conformation. This is an unstable and transient state that passes between trimeric subunits but is nevertheless an exposed state to be targeted for neutralizing antibody therapy. Polyclonal antibodies to the RBD of the SARS-CoV-2 protein have been shown to inhibit interaction with the ACE-2 receptor, confirming RBD as an attractive target for vaccinations or antiviral therapy.  Recombinant Rat GFRAL/GFR alpha-like Protein,His Tag重组肠激酶为采用重组大肠杆菌分泌表达的高纯度、高活性、高特异的牛肠激酶，不含其他蛋白酶。

Recombinant Biotinylated Human AFP (HLA-A*02:03) Protein,His-Avi Tag性能参数表达区间及表达系统（Source）RecombinantBiotinylatedHumanAFP(HLA-A*02:03)ProteinisexpressedfromHEK293withHistagandAvitagattheC-terminal..ItcontainsGly25-Thr305(HLA-A*02:03),Ile21-Met119(B2M)andFMNKFIYEIpeptide.[Accession|AAA03604.1(HLA-A*02:03)&P61769(B2M)&FMNKFIYEI]分子量大小（MolecularWeight）TheproteinhasapredictedMWof50.70kDa.Duetoglycosylation,theproteinmigratesto53-60kDabasedonTris-BisPAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.纯度（Purity）>95%asdeterminedby>95%asdeterminedbyHPLC制剂（Formulation）Lyophilizedfrom0.22μmfilteredsolutioninPBS(pH7.4).Normally8%trehaloseisaddedasprotectantbeforelyophilization.重构方法（Reconstitution）Centrifugetubesbeforeopening.Reconstitutingtoaconcentrationmorethan100μg/mlisrecommended.Dissolvethelyophilizedproteinindistilledwater.

Recombinant Biotinylated Human HLA-A*02:01&B2M&MAGE-A4 or MAGE-A8 (KVLEHVVRV) Monomer Protein,His-Avi Tag性能参数分子别名（Synonyms）MAGE-A4orMAGE-A8;MAGE-A4;MAGE-A8;表达区间及表达系统（Source）BiotinylatedHumanHLA-A*02:01&B2M&MAGE-A4orMAGE-A8(KVLEHVVRV)MonomerProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.ItcontainsGly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)andKVLEHVVRVpeptide.[Accession|A0A140T913(HLA-A*02:01)&P61769(B2M)&KVLEHVVRV]分子量大小（MolecularWeight）TheproteinhasapredictedMWof50.50kDa.Duetoglycosylation,theproteinmigratesto52-62kDabasedonSDS-PAGEresult.（Endotoxin）Lessthan1EUperμgbytheLALmethod.纯度（Purity）>95%asdeterminedbySDS-PAGEandHPLC.制剂（Formulation）Suppliedas0.22μmfilteredsolutioninPBS(pH7.4).储存条件Theproductshouldbestoredat-85~-65℃还具有抑制髓样细胞增殖的能力，髓样细胞增殖是Eotaxin不共有的生物学功能。

PE-labeled Human HLA-A*02:01&B2M&P53 R175H (HMTEVVRHC) Tetramer Protein,His-Avi Tag性能参数表达区间及表达系统（Source）PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerProteinisexpressedfromHEK293withHistagandAvitagattheC-Terminus.PE-labeledHumanHLA-A*02:01&B2M&P53R175H(HMTEVVRHC)TetramerisassembledbybiotinylatedmonomerandPE-labeledstreptavidin.ItcontainsGly25-Thr305(HLA-A*02:01),Ile21-Met119(B2M)andHMTEVVRHCpeptide.（Endotoxin）Lessthan1EUperμgbytheLALmethod.制剂（Formulation）Suppliedas0.22μmfilteredsolutionin20mMPB,500mMNaCl,0.2%BSA(pH8.0).储存条件Theproductshouldbestoredat-85~-65℃for3monthfromdateofreceipt.Recommendtoaliquottheproteinintosmallerquantitieswhenfirstusedandavoidrepeatedfreeze-thawcycles.LAG-1与MIP-1β（ACT II同种型）相同，Lag-1趋化吸引力单核细胞，并表现出活性作为HIV抑制因子。Recombinant Human IL-15RA&IL-15 Protein,His Tag

α-凝血酶（α-Thrombin）可以启动XIII因子和血小板，或者用作血管收缩剂。Recombinant Human FSTL3 Protein,His Tag

糖苷酶F(PNGaseF)是一种酰胺水解酶，经过和平空间站伊丽莎菌克隆，主要由脑膜炎脓杆菌等革兰氏阴性菌分泌。N-糖苷酶F(PNGaseF)在酵母中重组表达（比活性：100000U/mL），可以裂解由天冬酰胺连接的高甘露糖、杂合和复杂的寡糖糖蛋白。PNGaseF的切割位点为糖蛋白内侧N-乙酰葡萄糖胺（GlcNAc）和天冬酰氨残基之间的酰胺键，同时将酶解后蛋白上的天冬氨酰转化为天冬氨酸。本产品带his标签，常应用于抗体及其相关蛋白完全去糖基化。另外，我司还提供其他类型的糖苷酶，包括酵母重组表达的N-糖苷酶F（比活性：750000U/mL），内切糖苷酶H，内切糖苷酶S。产品信息产品性质中文别名（Chinesesynonym）N-糖酰胺酶F；N-糖苷酶F英文别名（Englishsynonym）PNGaseF来源（Source）酵母重组表达分子量（Molecularweight）36kDa比活性（Specificactivity）100000U/mL缓冲液组分（Buffer）20mMTris-HClpH7.5,50mMNaCl,5mMEDTA,50%GlycerolRecombinant Human FSTL3 Protein,His Tag